［1］Sturgeon JF，Moore MJ.Non-risk-adapted surveillance in clinical stage Ⅰ nonseminomatous germ cell tumors：The princess margaret hospital's experience［J］.European Urology，2011，5：556-562.
［2］Olson TA，Murray MJ.Pediatric and adolescent extracranial germ cell tumors：The road to collaboration［J］.Journal of Clinical Oncology，2015，11：3018-3028.
［3］Niramis R，Anuntkosol M，Buranakitjaroen V，et al.Longterm outcomes of sacrococcygeal germ cell tumors in infancy and childhood［J］.Surg Res Pract，2015，2015：398549.
［4］Kim J，Lee NH，Lee SH，et al.Prognostic factors in children with extracranial germ cell tumors treated with cisplatinbased chemotherapy［J］.Korean J Pediatr，2015，58(10)：386-391.
［5］Dolci S，Campolo F.Gonadal development and germ cell tumors in mouse and humans［J］.Seminars in Cell & Developmental Biology，2015：1-10.
［6］Christina E.Application of stem cell markers in search for neoplastic germ cells in dysgenetic gonads，extragonadaltumours，and in semen of infertile men［J］.Cancer Treatment Reviews ，2008，34：348-367.
［7］Puumala SE，Ross JA.Pediatric germ cell tumors and parental infertility and infertility treatment：A children's oncology group report［J］.Cancer Epidemiology，2011，35：25-31.
［8］Rogers PC，Olson TA，Cullen JW，et al.Treatment of children and adolescents with stage Ⅱ testicular and stages Ⅰ and Ⅱ ovarian malignant germ cell tumors：A pediatric intergroup study-pediatric oncology group 9048 and children's cancer group 8891［J］.J Clin Oncol，2004，22(17)：3563-3569.
［9］Agarwala S，Mitra A，Bansal D，et al.Management of pediatric malignant germ cell tumors：ICMR consensus document［J］.Indian J Pediatr，2017，84(6)：465-472.
［10］Cushing B，Giller R，Cullen JW，et al.Randomized comparison of combination chemotherapy with etoposide，bleomycin，and either high-dose or standard-dose cisplatin in children and adolescents with high-risk malignant germ cell tumors：A pediatric intergroup study-pediatric oncology group 9049 and children's cancer group 8882［J］.J Clin Oncol，2004，22：2691-2700.
［11］Mann JR，Raafat F，Robinson K，et al.The united kingdom children's cancer study group's second germ cell tumor study：Carboplatin，etoposide，and bleomycin are effective treatment for children with malignant extracranial germ cell tumors，with acceptable toxicity［J］.J Clin Oncol ，2000，18：3809-3818.
［12］He Kejun，Yuan Xiaojun.Effecacy of protocol JEB in 22 children with yolk sac tumors［J］.Chin J Clin Oncol，2012，39(15)：1043-1045.［何珂骏，袁晓军.JEB 方案治疗22 例儿童卵黄囊瘤的临床疗效分析［J］.中国肿瘤临床，2012，39(15)：1043-1045.］
［13］Shaikh F，Cullen JW，Olson TA，et al.Reduced and compressed cisplatin-based chemotherapy in children and adolescents with intermediate-risk extracranial malignant germ cell tumors：A report from the children's oncology group［J］.J Clin Oncol，2017，35(11)：1203-1210.
［14］Pashankar F，Frazier AL，Krailo M，et al.Treatment of refractory germ cell tumors in children with paclitaxel，ifosfamide，and carboplatin：A report from the children's oncology group AGCT0521 study［J］.Pediatr Blood Cancer，2018，26：e27111.
［15］Yan QH，Tang JY，Pan Ci，et al.Study on the clinical outcomes of children with stage Ⅳ malignant extracranial germ cell tumors［J］.Journal of Clinical Pediatrics，2017，35(5)：321-324.［姚强华，汤静燕，潘慈，等.儿童Ⅳ期颅外恶性生殖细胞肿瘤疗效观察［J］.临床儿科杂志，2017，35(5)：321-324.］
［16］Lu SY，Sun XF，Zhen ZJ，et al.Survival analysis of children with stage Ⅱ testicular malignant germ cell tumors treated with surgery or surgery combined with adjuvant chemotherapy［J］.Chin J Cancer，2015，34(2)：86-93.